ferric ferrocyanide has been researched along with Breast Cancer in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cotchim, S; Kanatharana, P; Kongkaew, S; Limbut, W; Thavarungkul, P | 1 |
| Akakuru, OU; Feng, Q; Liu, C; Lu, Z; Shou, P; Tu, J; Wu, A; Wu, Y; Xing, J; Ye, Z; Yu, Z; Zhang, L; Zhang, X; Zhou, B | 1 |
| Hao, Y; Li, J; Liu, Y; Liu, YN; Lou, D; Sun, X; Tao, N; Wu, Y | 1 |
| Cheng, Y; Li, J; Li, N; Li, W; Liu, P; Lu, Q; Ren, C; Tan, F; Xu, M; Yang, L | 1 |
| Cai, X; Gao, W; Hao, J; Wu, J; Xie, X; Zheng, Y | 1 |
| Liu, WF; Liu, Y; Lu, GM; Su, YY; Teng, ZG; Tian, W; Tian, Y; Wang, SJ; Yao, H; Zhang, LJ; Zhang, XD; Zhao, S | 1 |
| Gao, Y; Hou, M; Kang, Y; Li, Q; Sun, L; Xu, Z; Xue, P; Yang, R; Zhang, L | 1 |
| Cai, X; Chen, J; Chen, L; Chen, Y; Gao, W; Hu, B; Tang, X; Tian, Q; Xu, Y; Yang, S; Zhang, Y; Zheng, Y | 1 |
| Ding, L; Li, H; Li, XW; Tang, JH; Wu, Y; Zhang, W | 1 |
| Daniyal, M; Fan, J; Jian, Y; Li, B; Liu, B; Long, Y; Ma, X; Tong, C; Wang, W; Xiao, F; Xie, Q | 1 |
| Cai, X; Chen, H; Gao, W; Hao, L; Sheng, D; Wang, R; Wang, Z; Xu, C; Yao, Y; Zhang, N; Zheng, Y | 1 |
| Li, Q; Parchur, AK; Zhou, A | 1 |
12 other study(ies) available for ferric ferrocyanide and Breast Cancer
| Article | Year |
|---|---|
Disposable label-free electrochemical immunosensor based on prussian blue nanocubes for four breast cancer tumor markers.
Topics: Antibodies; Biomarkers, Tumor; Biosensing Techniques; Breast Neoplasms; Electrochemical Techniques; Electrodes; Female; Humans; Immunoassay | 2023 |
Zn
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Ferrocyanides; Humans; Hyperthermia, Induced; Infrared Rays; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Nanostructures; Particle Size; Photosensitizing Agents; Photothermal Therapy; Theranostic Nanomedicine; Tissue Distribution; Xenograft Model Antitumor Assays; Zinc | 2020 |
A robust hybrid nanozyme@hydrogel platform as a biomimetic cascade bioreactor for combination antitumor therapy.
Topics: Animals; Biomimetic Materials; Bioreactors; Breast Neoplasms; Combined Modality Therapy; Delayed-Action Preparations; Drug Synergism; Female; Ferrocyanides; Glucose Oxidase; Hydrogels; Hydrogen Peroxide; Hyperthermia, Induced; Mice; Nanoparticles; Phototherapy; Polysaccharides, Bacterial; Xenograft Model Antitumor Assays | 2020 |
Ultra-small Bi
Topics: Animals; Bismuth; Breast Neoplasms; Female; Ferrocyanides; Humans; Hydrogen Peroxide; Iron; MCF-7 Cells; Mice; Nanostructures; Oxidative Stress; Phototherapy; Quantum Dots; Radiotherapy; Reactive Oxygen Species; Sulfides; Xenograft Model Antitumor Assays | 2020 |
Self-synergistic effect of Prussian blue nanoparticles for cancer therapy: driving photothermal therapy and reducing hyperthermia-induced side effects.
Topics: Animals; Breast Neoplasms; Female; Ferrocyanides; Hyperthermia; Hyperthermia, Induced; Inflammation; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Photosensitizing Agents; Photothermal Therapy; RAW 264.7 Cells; Reactive Oxygen Species | 2021 |
Ag-HPBs by a coating-etching strategy and their derived injectable implants for enhanced tumor photothermal treatment.
Topics: Animals; Breast Neoplasms; Female; Ferrocyanides; Humans; Hyperthermia, Induced; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Phototherapy; Prostheses and Implants; Silver; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Light-activatable Chlorin e6 (Ce6)-imbedded erythrocyte membrane vesicles camouflaged Prussian blue nanoparticles for synergistic photothermal and photodynamic therapies of cancer.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chlorophyllides; Combined Modality Therapy; Erythrocyte Membrane; Female; Ferrocyanides; Humans; Hypothermia, Induced; Light; Materials Testing; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Tissue Distribution | 2018 |
Large-scale synthesis of monodisperse Prussian blue nanoparticles for cancer theranostics via an "in situ modification" strategy.
Topics: Administration, Intravenous; Animals; Antidotes; Apoptosis; Breast Neoplasms; Cell Proliferation; Female; Ferrocyanides; Humans; Mice; Mice, Nude; Nanoparticles; Theranostic Nanomedicine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Prussian blue-modified ferritin nanoparticles for effective tumor chemo-photothermal combination therapy via enhancing reactive oxygen species production.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Female; Ferritins; Ferrocyanides; Hyperthermia, Induced; Mice; Mice, Inbred BALB C; Nanomedicine; Nanoparticles; Phototherapy; RAW 264.7 Cells; Reactive Oxygen Species | 2019 |
RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer.
Topics: Animals; Apoptosis; Breast Neoplasms; Bufanolides; Cell Line, Tumor; Combined Modality Therapy; Erythrocyte Membrane; Female; Ferrocyanides; Hemolysis; Humans; Hyaluronic Acid; Hyperthermia, Induced; Immune Evasion; Mice; Mice, Inbred BALB C; Nanoparticles; NIH 3T3 Cells; Phototherapy; Reactive Oxygen Species | 2019 |
A Multifunctional Theranostic Nanoagent for Dual-Mode Image-Guided HIFU/Chemo- Synergistic Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cattle; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Drug Carriers; Female; Ferrocyanides; Fluorocarbons; High-Intensity Focused Ultrasound Ablation; Humans; Liver; Nanoparticles; Optical Imaging; Photoacoustic Techniques; Rabbits; Theranostic Nanomedicine | 2016 |
Near-infrared photothermal therapy of Prussian-blue-functionalized lanthanide-ion-doped inorganic/plasmonic multifunctional nanostructures for the selective targeting of HER2-expressing breast cancer cells.
Topics: Antibodies, Monoclonal; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Contrast Media; Female; Ferrocyanides; Gold; Humans; Infrared Rays; Ions; Lanthanoid Series Elements; Leukocytes; Molecular Targeted Therapy; Nanostructures; Nanotubes; Particle Size; Phototherapy; Reactive Oxygen Species; Receptor, ErbB-2; Silicon Dioxide; Surface Properties | 2016 |